Publications by authors named "Nabil Asahaad"
Article Synopsis
- This study focuses on chronic subdural hematoma (CSDH) treatment, specifically how a portion of patients can resolve their condition without surgery, despite standard treatment typically involving an operation.
- Data were gathered from patients treated conservatively at three hospitals in the Netherlands, with a primary goal of identifying factors that allow patients to avoid further treatment within three months of diagnosis.
- Results show that 73% of patients did not need additional treatment, often having smaller hematoma volumes, indicating that further research is necessary to determine which patients truly need surgery versus those who can be treated conservatively.
Background: Long door-in-door-out (DIDO) times are an important cause of treatment delay in patients transferred for endovascular thrombectomy (EVT) from primary stroke centres (PSC) to an intervention centre. Insight in causes of prolonged DIDO times may facilitate process improvement interventions. We aimed to quantify different components of DIDO time and to identify determinants of DIDO time.
View Article and Find Full Text PDFBackground: We aimed to quantify the need for additional surgery in patients with chronic subdural hematoma (CSDH) primarily treated with dexamethasone and to identify patient characteristics associated with additional surgery.
Methods: Data were retrospectively collected from 283 patients with CSDH, primarily treated with dexamethasone, in 3 hospitals from 2008 to 2018. Primary outcome was the need for additional surgery.